These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27444932)

  • 1. Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
    Ngo D; Sinha S; Shen D; Kuhn EW; Keyes MJ; Shi X; Benson MD; O'Sullivan JF; Keshishian H; Farrell LA; Fifer MA; Vasan RS; Sabatine MS; Larson MG; Carr SA; Wang TJ; Gerszten RE
    Circulation; 2016 Jul; 134(4):270-85. PubMed ID: 27444932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions.
    Jacob J; Ngo D; Finkel N; Pitts R; Gleim S; Benson MD; Keyes MJ; Farrell LA; Morgan T; Jennings LL; Gerszten RE
    Circulation; 2018 Mar; 137(12):1270-1277. PubMed ID: 29222138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury.
    Lewis GD; Wei R; Liu E; Yang E; Shi X; Martinovic M; Farrell L; Asnani A; Cyrille M; Ramanathan A; Shaham O; Berriz G; Lowry PA; Palacios IF; Taşan M; Roth FP; Min J; Baumgartner C; Keshishian H; Addona T; Mootha VK; Rosenzweig A; Carr SA; Fifer MA; Sabatine MS; Gerszten RE
    J Clin Invest; 2008 Oct; 118(10):3503-12. PubMed ID: 18769631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease.
    Ganz P; Heidecker B; Hveem K; Jonasson C; Kato S; Segal MR; Sterling DG; Williams SA
    JAMA; 2016 Jun; 315(23):2532-41. PubMed ID: 27327800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer-Based Proteomic Platform Identifies Novel Protein Predictors of Incident Heart Failure and Echocardiographic Traits.
    Nayor M; Short MI; Rasheed H; Lin H; Jonasson C; Yang Q; Hveem K; Felix JF; Morrison AC; Wild PS; Morley MP; Cappola TP; Benson MD; ; ; Ngo D; Sinha S; Keyes MJ; Shen D; Wang TJ; Larson MG; Brumpton BM; Gerszten RE; Omland T; Vasan RS
    Circ Heart Fail; 2020 May; 13(5):e006749. PubMed ID: 32408813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic Discovery and Validation of the Confounding Effect of Heparin Administration on the Analysis of Candidate Cardiovascular Biomarkers.
    Beck HC; Jensen LO; Gils C; Ilondo AMM; Frydland M; Hassager C; Møller-Helgestad OK; Møller JE; Rasmussen LM
    Clin Chem; 2018 Oct; 64(10):1474-1484. PubMed ID: 30115630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new data mining approach for profiling and categorizing kinetic patterns of metabolic biomarkers after myocardial injury.
    Baumgartner C; Lewis GD; Netzer M; Pfeifer B; Gerszten RE
    Bioinformatics; 2010 Jul; 26(14):1745-51. PubMed ID: 20483816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.
    Keshishian H; Burgess MW; Gillette MA; Mertins P; Clauser KR; Mani DR; Kuhn EW; Farrell LA; Gerszten RE; Carr SA
    Mol Cell Proteomics; 2015 Sep; 14(9):2375-93. PubMed ID: 25724909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.
    Addona TA; Shi X; Keshishian H; Mani DR; Burgess M; Gillette MA; Clauser KR; Shen D; Lewis GD; Farrell LA; Fifer MA; Sabatine MS; Gerszten RE; Carr SA
    Nat Biotechnol; 2011 Jun; 29(7):635-43. PubMed ID: 21685905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer-based proteomics of serum and plasma in acquired aplastic anemia.
    Giudice V; Biancotto A; Wu Z; Cheung F; Candia J; Fantoni G; Kajigaya S; Rios O; Townsley D; Feng X; Young NS
    Exp Hematol; 2018 Dec; 68():38-50. PubMed ID: 30312735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of proteomic-based tools for improved biomarkers of myocardial injury.
    Gerszten RE; Carr SA; Sabatine M
    Clin Chem; 2010 Feb; 56(2):194-201. PubMed ID: 20022985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Architecture of the Cardiovascular Risk Proteome.
    Benson MD; Yang Q; Ngo D; Zhu Y; Shen D; Farrell LA; Sinha S; Keyes MJ; Vasan RS; Larson MG; Smith JG; Wang TJ; Gerszten RE
    Circulation; 2018 Mar; 137(11):1158-1172. PubMed ID: 29258991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial Injury Is Distinguished from Stable Angina by a Set of Candidate Plasma Biomarkers Identified Using iTRAQ/MRM-Based Approach.
    Cheow ESH; Cheng WC; Yap T; Dutta B; Lee CN; Kleijn DPV; Sorokin V; Sze SK
    J Proteome Res; 2018 Jan; 17(1):499-515. PubMed ID: 29068691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of proteomic methods in evaluating biomarker-AKI associations in cardiac surgery patients.
    Liu RX; Thiessen-Philbrook HR; Vasan RS; Coresh J; Ganz P; Bonventre JV; Kimmel PL; Parikh CR
    Transl Res; 2021 Dec; 238():49-62. PubMed ID: 34343625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.
    George MJ; Kleveland O; Garcia-Hernandez J; Palmen J; Lovering R; Wiseth R; Aukrust P; Engmann J; Damås JK; Hingorani AD; Gullestad L; Casas JP; Ueland T
    J Am Heart Assoc; 2020 Jun; 9(12):e015628. PubMed ID: 32515246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: proteomic analysis of cardiac tissues from patients.
    Kakimoto Y; Ito S; Abiru H; Kotani H; Ozeki M; Tamaki K; Tsuruyama T
    J Am Heart Assoc; 2013 Dec; 2(6):e000565. PubMed ID: 24342996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiographic and clinical characteristics of type 1 versus type 2 perioperative myocardial infarction.
    Hanson I; Kahn J; Dixon S; Goldstein J
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):622-8. PubMed ID: 22926992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aptamer-based trypsin reactor for on-line protein digestion with electrospray ionization tandem mass spectrometry.
    Xiao P; Lv X; Wang S; Iqbal J; Qing H; Li Q; Deng Y
    Anal Biochem; 2013 Oct; 441(2):123-32. PubMed ID: 23831476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative.
    Yin X; Subramanian S; Hwang SJ; O'Donnell CJ; Fox CS; Courchesne P; Muntendam P; Gordon N; Adourian A; Juhasz P; Larson MG; Levy D
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):939-45. PubMed ID: 24526693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.